Pietro Quaglino

80PUBLICATIONS
256CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AllergyRespiratory diseasesHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (80)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jun 30, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.

|Jun 10, 2026
Beyond the Kidney and Lung: Cutaneous and Mucosal Clues to Human Hantavirus Disease.

|May 25, 2026
Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.

|May 18, 2026
Early On-Treatment Change in SALT as a Pragmatic Predictor of Ritlecitinib Response in Moderate-To-Severe Alopecia Areata: A Real-World Cohort Study.

|Apr 20, 2026
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI).

Pageof 14

Frequent Collaborators

55 joint publications

Simone Ribero

21 joint publications

Luca Mastorino

14 joint publications

Angelo Valerio Marzano

10 joint publications

Gianluca Avallone